GL1X · GenesisL1 explorer

MolNFT v1 · #113350 · protein

Vim-2-ox, discovery of novel inhibitor scaffolds against the metallo- beta-lactamase vim-2 by spr based fragment screening

5ACV: “Vim-2-ox, discovery of novel inhibitor scaffolds against the metallo- beta-lactamase vim-2 by spr based…”. X-ray diffraction, 3 ligands (ZN, CL, OH), 3 pockets (best druggability 0.74). MolNFT v1 #113350 on GenesisL1: 3D structure…

PDB
5ACV
Type
protein
Length
466 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q9K2N0
Ligands
ZN, CL, OH
Pockets
3 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 27% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBeta-lactamase (EC 3.5.2.6)protein23327% helix, 30% strandQ9K2N0

Ligands and binding sites

  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • CL · Chloride ion · ion · 4 copies · chains A, B
  • OH · Hydroxide ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17090.740.8067OH
2690.360.7718empty
3520.300.7618empty

Interfaces

1 interface between chains.

  • A–B · 585 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (oxidation).

Compared structures

  • 5ACV · VIM-2-OX, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.